The BCL2L1 gene, which is part of the SUM-185 functional oncogene signature, was of particular interest because a role for amplified BCL2L1 as a driver oncogene in breast cancer has not been previously characterized. This evidence concerns the gene BCL2L1 and breast carcinoma.